Abstract | BACKGROUND: METHOD: Supported by parental consent and a second opinion, standardised observations were used to chart the progress of treatment with clozapine in a child in-patient detained under mental health legislation with severe drug-resistant schizophrenia and tardive dyskinesia. RESULTS: Sixteen months of clozapine treatment led to significant reduction of symptomatology with marked improvement in social functioning and diminished tardive dyskinesia. CONCLUSIONS:
|
Authors | T H MacEwan, M J Morton |
Journal | The British journal of psychiatry : the journal of mental science
(Br J Psychiatry)
Vol. 168
Issue 3
Pg. 376-8
(Mar 1996)
ISSN: 0007-1250 [Print] England |
PMID | 8833696
(Publication Type: Case Reports, Journal Article)
|
Chemical References |
- Antipsychotic Agents
- Clozapine
|
Topics |
- Antipsychotic Agents
(administration & dosage, adverse effects, therapeutic use)
- Child
- Clozapine
(administration & dosage, adverse effects, therapeutic use)
- Humans
- Male
- Schizophrenia
(drug therapy)
|